Need professional-grade analysis? Visit stockanalysis.com
$200.27M
N/A
491
N/A
Mayne Pharma Group Ltd (MYX) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at AUD2.63, up 4.78% from the previous close.
Over the past year, MYX has traded between a low of AUD2.16 and a high of AUD7.12. The stock has lost 62.0% over this period. It is currently 63.1% below its 52-week high.
Mayne Pharma Group Ltd has a market capitalization of $200.27M.
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Side-by-side comparison against top Healthcare peers.